William Wing Yan Dr Lo
Director · Regencell Bioscience Holdings Ltd
- 2026
- May 29, 2026
- 1
Summary
Latest filing:
William Wing Yan Dr Lo is Director of Regencell Bioscience Holdings Ltd (RGC). 1 SEC Form 4 filing on record, dated 29 May 2026.
Trading pattern
InsiderAlpha's records for William Wing Yan Dr Lo go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same sector
No other insider has filed at William Wing Yan Dr Lo's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M in KLRA purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
- Stephen M. Bloch - $125.05M in LQDA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is William Wing Yan Dr Lo?
William Wing Yan Dr Lo is a corporate insider, tracked as Director of Regencell Bioscience Holdings Ltd (RGC). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did William Wing Yan Dr Lo last file a Form 4?
The only primary Form 4 on record is dated 29 May 2026.